Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ

Closed
OC-2026-132216Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The U.S. Food and Drug Administration (FDA), through its Office of Acquisitions and Grants Services, plans to release a competitive solicitation for a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract to provide comprehensive support services in occupational safety, industrial hygiene, information systems, and training. This contract aims to support FDA-wide needs in areas such as laboratory quality, biosafety, and related compliance programs. The acquisition will follow federal acquisition regulations relevant to commercial products, negotiated contracting, and indefinite-delivery contracts. The contract will have an anticipated five-year ordering period with a maximum ceiling of $14.5 million and will issue task orders using various pricing methods including Firm-Fixed-Price, Time-and-Materials, Labor-Hour, or hybrid approaches. The scope of services under this IDIQ contract encompasses a broad range of activities, including occupational safety and laboratory quality support, primary barrier equipment maintenance and certification, industrial hygiene assessments, information system support, training development, compliance and policy assistance, and biosafety-related services such as BSL-3 laboratory re-verification and vaporized hydrogen peroxide decontamination. Activities will primarily take place at the FDA Headquarters in Silver Spring, Maryland, with potential work at additional FDA sites nationwide. The agency has provided a draft solicitation for industry review to aid in planning, with the official solicitation expected to be posted around June 2026 on SAM.gov. Interested offerors must be registered in SAM to participate, and this notice serves strictly informational purposes, with no proposals requested or contract awards pending at this time.

General Info

FDA seeks single-award IDIQ contract for occupational safety, industrial hygiene, training support up to $14.5M.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

NAICS

541690 - Other Scientific and Technical Consulting ServicesView NAICS

Place of Performance

Silver Spring, MD, USA

Set-Aside

NONE

Documents

(12)

75F40126R00020 FDA OOSH Workstream Performance Work Statement

PDFpws

FDA Commitment to Protect Non-Public Information Employee Agreement

PDFnon-disclosure-agreement

Attachment C2 - OSIST Facility Inventory Summary

PDFother

Attachment R4 Past Performance Questionnaire

PDFpast-performance

RFP 75F40126R00020 OSIST Price Workbook Instructions and Pricing

XLSXprice-workbook

Attachment C5 - FDA Contractor Personnel Security Clearance Standards Oct 2017

PDFsecurity-clearance-standards

75F40126R00020 FDA OSIST Performance Work Statement

PDFpws

CBER BSL-3 Suites Annual Re-Verification PWS Task Order 0001

PDFpws

75F40126R00020 FDA OSIST Draft RFP

PDFrfp

HHS Subcontracting Plan Template Rev. February 2024

PDFsubcontracting-plan

75F40126R00020 FDA OSIST RFP Q&A Template

XLSXq-and-a

R2 CBER BSL-3 Areas for Decontamination Equipment List

PDFspecifications

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts2 people available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Office AddressRockville, MD, 20852, USA

Full Description

Show more

Amendment No. 0001 – Industry Questions Regarding Draft Solicitation Documents


The purpose of this amendment is to encourage industry review of the draft solicitation package and associated documents and to invite the submission of questions for Government consideration prior to release of the final solicitation.


The Government encourages interested parties to review the draft solicitation, Performance Work Statements (PWSs), attachments, exhibits, pricing workbook, and all associated acquisition documents provided with this pre-solicitation notice. Offerors are encouraged to identify and submit questions, ambiguities, inconsistencies, or areas requiring clarification utilizing the attached R5_OSIST RFP Q&A Template.


The Government anticipates issuing the official solicitation with an abbreviated proposal response period following release. Accordingly, interested parties are strongly encouraged to conduct a thorough review of all draft solicitation materials and submit questions during this pre-solicitation phase. Early submission of questions will assist prospective offerors in preparing responsive proposals and facilitate a more efficient solicitation process.


Questions shall be submitted electronically using the Government-provided Q&A Template no later than Tuesday, June 16, 2026. The Government reserves the right to consolidate, paraphrase, or otherwise group similar questions when preparing responses. Responses to questions may be incorporated into the final solicitation, issued through solicitation amendments, or otherwise addressed at the Government's discretion.


Submission of questions during this pre-solicitation period is voluntary and is intended solely to assist the Government in refining solicitation requirements prior to issuance of the formal solicitation.


All other terms and conditions of the pre-solicitation synopsis remain unchanged.


Original


Description


The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), intends to issue a competitive Full and Open solicitation for the award of a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract for Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) support services.


The contemplated acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Products and Commercial Services; FAR Part 15, Contracting by Negotiation; and FAR Part 16.5, Indefinite-Delivery Contracts. The Government intends to award one (1) IDIQ contract resulting from Solicitation No. 75F40126R00020.


The resultant IDIQ contract is anticipated to support FDA enterprise-wide occupational safety, industrial hygiene, laboratory quality, biosafety, information systems, and training requirements through issuance of individual task orders. Task orders may be issued on a Firm-Fixed-Price (FFP), Time-and-Materials (T&M), Labor-Hour (LH), or hybrid basis.


The anticipated ordering period is five (5) years from date of award. The anticipated maximum contract ceiling is $14,500,000. The guaranteed minimum will be satisfied through issuance of the initial task order at time of award.


Services to be performed under the resultant IDIQ contract include, but are not limited to:


  • Occupational safety and laboratory quality support services;
  • Primary barrier equipment maintenance, repair, and certification;
  • Industrial hygiene assessments and program support;
  • Information and data systems support;
  • Training development and management;
  • Policy, compliance, and programmatic support services;
  • BSL-3 laboratory re-verification and certification support;
  • HVAC airflow and pressure differential testing;
  • Vaporized hydrogen peroxide (VHP) decontamination services; and
  • Biosafety compliance assessments aligned with CDC, NIH, USDA/APHIS, OSHA, ANSI, ISO, and related federal standards.

Primary performance will occur at FDA Headquarters located at the White Oak Federal Research Center, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, with additional performance possible at FDA facilities nationwide.


The Government is attaching a draft version of Solicitation No. 75F40126R00020 for industry review and planning purposes. The attached draft Request for Proposal (RFP) is provided to assist prospective offerors in understanding the anticipated scope and structure of the requirement and does not constitute the final solicitation. The draft solicitation is subject to change prior to formal issuance of the official solicitation on SAM.gov.


This synopsis and attached draft solicitation are issued for informational and planning purposes only. The Government is not requesting proposals, capability statements, comments, questions, or responses at this time. No contract award will be made as a result of this notice. Any future solicitation will be separately posted to SAM.gov.


The Government anticipates issuance of the formal solicitation on or about June 2026 via SAM.gov.



Important Notice to Interested Offerors


Offerors must be registered in the System for Award Management (SAM) at https://sam.gov at the time of proposal submission, prior to award, and throughout contract performance.


This notice is issued solely for informational and planning purposes and does not constitute a solicitation. This synopsis shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. The Government will not reimburse respondents for any costs incurred in preparation of responses to this notice.